FELICITAS OKWARA: Open Payments
NPI 1730783762 · FRIENDSWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 14 payments from 7 companies in 2025. Trend: 2023 $904 · 2024 $955 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
| Alkermes, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
Products named: COBENFY, ARISTADA, REXULTI, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, SPRAVATO.
Industry payments across TX — which companies pay providers there.
